“Scientific innovation is not the only route to higher R&D productivity. Attention to the familiar management areas of cost, speed, and decision making can still reap rewards.”

According to a survey of R&D directors in the world’s 30 largest health care and manufacturing companies, open innovation is becoming an established part of their culture, and benefits are being recognized.

Batelle and R&D magazine recently released their R&D forecast for 2010. Based in Columbus, Ohio, Batelle is the world’s largest, independent research and development organization. According to the 2010 Global R&D Funding Report, U.S. R&D will “begin to re-emerge in 2010, with total R&D spending reaching $401.9 billion, up 3.27% over the final 2009 estimate of $389.2 billion.”

Via Life Science Leader
“There is mounting pressure across all the biopharma industry to innovate constantly in order to fill or maintain pipelines, allowing the companies to reach new markets and meet emerging unmet needs. This …